Signalling strength determines proapoptotic functions of STING.
Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F, Ablasser A. · 2017
Read Signalling strength determines proapoptotic functions of STING. by Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F, Ablasser A. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5585373.txt.
Introduction
Gulen and co-authors report an immunity study in Nature Communications. Cells sense loose DNA inside them through a pathway called cGAS-STING. In most immune cells, that alarm turns on antiviral genes. The team asks what the same alarm does in T cells.
T cells carry high levels of STING, so their response runs stronger. Instead of mainly making interferons, they switch on death genes. The cells then die by apoptosis. Cancerous T cells kept this response. Drugs that activate STING stopped T-cell tumors growing in mice. The effect did not depend on STING's usual helper role for vaccines. Readers learn that signal strength, not just signal presence, shapes the outcome.
Catalog record
| CREATOR | Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F, Ablasser A. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Signalling strength determines proapoptotic functions of STING By Muhammet F. Gulen, Ute Koch, Simone M. Haag, Fabian Schuler, Lionel Apetoh, Andreas Villunger, Freddy Radtke, Andrea Ablasser Published in: Nature Communications DOI: 10.1038/s41467-017-00573-w ABSTRACT Mammalian cells use cytosolic nucleic acid receptors to detect pathogens and other stress signals. In innate immune cells the presence of cytosolic DNA is sensed by the cGAS–STING signalling pathway, which initiates a gene expression programme linked to cellular activation and cytokine production. Whether the outcome of the STING response varies between distinct cell types remains largely unknown. Here we show that T cells exhibit an intensified STING response, which leads to the expression of a distinct set of genes and results in the induction of apoptosis. Of note, this proapoptotic STING response is still functional in cancerous T cells and delivery of small molecule STING agonists prevents in vivo growth of T-cell-derived tumours independent of its adjuvant activity. Our results demonstrate how the magnitude of STING signalling can shape distinct effector responses, which may permit for cell type-adjusted behaviours towards endogenous or exogenous insults. INTRODUCTION A fundamental feature of the innate immune system is the use of nucleic acid (NA) receptors as sensors for virus infection. In the cytosol of mammalian cells the best-characterised NA driven signal transduction pathways are the RIG-I like receptor (RLR) and cGAS–STING pathways, which detect RNA and DNA species, respectively1. Although RLRs and cGAS/STING have specificities for distinct ligands, both pathways engage a similar set of transcription factors, which coordinate the expression of type I interferons (IFN) and other antiviral and proinflammatory genes. Although traditionally viewed as a central part of the innate immune system, the expression of NA sensors is not restricted to professional antigen-presenting cells. Instead, RLRs and cGAS/STING are present in many mammalian cells. While much has been learned about the function of NA sensors in innate immune cells, less is known about their effector functions in other cell types. Identifying the signalling outputs of NA sensors is critical to understanding how antiviral networks are integrated into the specific cellular context within which they operate. The cytosolic recognition of double-stranded (ds) DNA through the cGAS–STING signalling pathway is crucial for the recognition of DNA viruses, but also other pathogens including retroviruses and intracellular bacteria. Upon binding cytosolic dsDNA, cGAS catalyses the synthesis of cyclic GMP-AMP (cGAMP 2ʹ3ʹ), which in turn engages STING as a second receptor2–6. After its activation STING recruits Tank binding kinase (TB K1), which then phosphorylates STING, thereby rendering STING capable of interacting with Interferon regulatory factor 3 (IRF-3)7. Phosphorylation of IRF-3, again mediated by TBK1, results in IRF-3 dissociation form STING, self-dimerisation and consequently IRF-3 translocation into the nucleus to regulate gene expression. In addition to IRF-3, Nuclear Factor Kappa B (NF-κB) is also a key element within the STING signalling cascade. The coordinated activation of transcription factors promotes the induction of various antiviral genes, in particular type I IFNs and IFN-stimulated genes (ISG). In addition, STING signalling is also associated with the production of many proinflammatory cytokines and chemokines. Although the cGAS–STING signalling pathway is best characterised for generating an antiviral response, increasing evidence indicates that cGAS and STING are also involved in the regulation of alternative, non-inflammatory cellular responses. For example, evidence exists that STING promotes cross-presentation, triggers autophagy and, in some instances, induces cell death8, 9–12. While these reports highlight diverse, type I IFN-independent functions of STING, the regulation of those remains less well characterised. Given their highly specific function in adaptive immunity, we decided to assess the response elicited by STING in T cells. Here, we show that T cells exhibit an alternate signalling outcome in response to small molecule STING agonists, which manifests in apoptosis rather than the production of type I IFNs. We find that the induction of apoptosis is due to high expression levels of STING in T cells, which triggers an intensified response that is associated with the induction of IRF-3-dependent and p53-dependent proapoptotic genes. Remarkably, this proapoptotic STING response is also functional in cancerous T cells. As such, pharmacological hyperactivation of STING prevents tumour growth of T-cell-derived cancers independent of its adjuvant activity. Together, our study uncovers the magnitude of STING signalling as a means through which STING generates proapoptotic effects and proposes to exploit this mechanism therapeutically in the context of T-cell-derived malignancies. RESULTS Induction of a proapoptotic STING response in T cells To determine the effect of STING activation in primary T cells, we used fluorescence-activated cell sorting (FACS) to isolate highly pure primary CD4+ T cells (hereafter referred to as T cells) from the spleens of wild-type (WT) mice and mice lacking STING (Goldenticket (STINGgt/gt))13. We found that STING was expressed at high levels in splenic T cells (Fig. 1a). To circumvent unspecific effects of liposomes on the activation status of T cells, we employed the cell permeable small molecule STING agonist 10-carboxymethyl-9-acridanone (CMA) for stimulation experiments14. Short-term treatment of undifferentiated CD4+ T cells with CMA resulted in phosphorylation of TBK1 and NF-κB p65 in WT cells but not in cells from STINGgt/gt mice (Fig. 1a). CMA elicited similar activities in in vitro differentiated Th1, Th2 and Th17 cells (Supplementary Fig. 1a). Thus, STING is active in T cells. STING signalling is best known to trigger the secretion of cytokines, especially type I IFNs and to induce the expression of ISGs. We therefore assessed the upregulation of type I IFNs (Ifnb1) and Ifit2 in T cells. CMA-treated T-cells induced expression of Ifnb1 and Ifit2 on mRNA level, however production of type I IFNs on protein level was not detectable when assessed by an IFN bioassay (Fig. 1b, c). Instead, when cultured in the presence of CMA overnight, T cells displayed visible signs of cell death (Fig. 1d). Similar to undifferentiated CD4+ T cells, CD8+ T cells and distinct in vitro differentiated T-cell subsets committed to cell death upon CMA treatment (Supplementary Fig. 1b, c). Further analysis of the mechanism of CMA-induced cell death revealed that T cells from WT mice, but not from STINGgt/gt mice, displayed Annexin V binding on their cell surface and triggered activation of caspases-3/7, both hallmarks of apoptotic cell death (Fig. 1e, f and Supplementary Fig. 2). These data indicate that the STING signalling pathway is functional in primary T cells, yet instead of triggering type I IFN production it results in the induction of apoptosis.Fig. 1STING activation induces apoptosis in T cells. a CD4+ T cells from wild-type (WT) or STINGgt/gt mice were treated with DMSO or 10-carboxymethyl-9-acridanone (CMA) for the indicated times and phosphorylation of TBK1 and NF-κB (p65) was assessed by immunoblot. b CD4+ T cells from WT or STINGgt/gt mice were treated with DMSO or CMA for 4 h and abundance of mRNAs of the indicated genes was measured by RT-qPCR. c Supernatants from CD4+ T cells or dendritic cells (DC) treated with DMSO or CMA were collected after 16 h. A bioassay was used to measure the production of type I IFNs (RLU relative light units). d, e CD4+ T cells from WT and STINGgt/gt mice were treated with DMSO or CMA. After 16 h cell viability d and percentage of apoptotic cells e, assessed by Annexin V staining, were determined. f WT